JPWO2021034418A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021034418A5 JPWO2021034418A5 JP2021578241A JP2021578241A JPWO2021034418A5 JP WO2021034418 A5 JPWO2021034418 A5 JP WO2021034418A5 JP 2021578241 A JP2021578241 A JP 2021578241A JP 2021578241 A JP2021578241 A JP 2021578241A JP WO2021034418 A5 JPWO2021034418 A5 JP WO2021034418A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- peptide
- pharmaceutical composition
- cell
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962869831P | 2019-07-02 | 2019-07-02 | |
| US62/869,831 | 2019-07-02 | ||
| PCT/US2020/040720 WO2021034418A2 (en) | 2019-07-02 | 2020-07-02 | Novel peptide, compositions and method for delivery of agents into cells and tissues |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022538903A JP2022538903A (ja) | 2022-09-06 |
| JP2022538903A5 JP2022538903A5 (https=) | 2023-07-11 |
| JPWO2021034418A5 true JPWO2021034418A5 (https=) | 2023-07-11 |
| JP7581264B2 JP7581264B2 (ja) | 2024-11-12 |
Family
ID=74659924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021578241A Active JP7581264B2 (ja) | 2019-07-02 | 2020-07-02 | 細胞および組織への薬剤の送達のための新規ペプチド、組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11713337B2 (https=) |
| EP (1) | EP3994151A4 (https=) |
| JP (1) | JP7581264B2 (https=) |
| KR (1) | KR20220039725A (https=) |
| CN (1) | CN114555625B (https=) |
| AU (1) | AU2020332268B2 (https=) |
| CA (1) | CA3144963A1 (https=) |
| IL (1) | IL289516A (https=) |
| WO (1) | WO2021034418A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3100276A1 (en) | 2018-06-06 | 2019-12-12 | Massachusetts Institute Of Technology | Circular rna for translation in eukaryotic cells |
| WO2026005189A1 (ko) * | 2024-06-27 | 2026-01-02 | 이엔셀 주식회사 | 안구 세포 또는 조직을 표적하는 펩타이드 및 이를 포함하는 바이러스 캡시드 단백질 및 바이러스 벡터 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5211657A (en) * | 1988-11-07 | 1993-05-18 | The United States Government As Represented By The Secretary Of The Department Of Health And Human Services | Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
| DE19827457C1 (de) * | 1998-06-19 | 2000-03-02 | Medigene Ag | Strukturprotein von AAV, seine Herstellung und Verwendung |
| US7396664B2 (en) | 1999-06-08 | 2008-07-08 | Regeneron Pharmaceuticals, Inc. | VEGF-binding fusion proteins and nucleic acids encoding the same |
| JP3635462B2 (ja) * | 2000-05-31 | 2005-04-06 | 国立医薬品食品衛生研究所長 | アデノウイルスベクター |
| SE0301431D0 (sv) * | 2003-05-19 | 2003-05-19 | Dermagen | Novel antimicrobial peptides |
| US8076295B2 (en) * | 2007-04-17 | 2011-12-13 | Nanotope, Inc. | Peptide amphiphiles having improved solubility and methods of using same |
| AU2008295509A1 (en) * | 2007-08-29 | 2009-03-12 | Tufts University | Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits |
| EP2187907A2 (en) * | 2007-09-11 | 2010-05-26 | Mondobiotech Laboratories AG | Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents |
| CN102869384B (zh) * | 2009-06-22 | 2016-01-13 | 伯纳姆医学研究所 | 使用带有c-端元件的肽和蛋白质的方法和组合物 |
| US20130158103A1 (en) * | 2011-11-23 | 2013-06-20 | The Curators Of The University Of Missouri | Method of Tissue-Selective Targeted Gene Transfer |
| EP3076792B1 (en) * | 2013-12-04 | 2020-11-11 | Newleaf Symbiotics, Inc. | Compositions and methods for improving lettuce production |
| US10316061B2 (en) * | 2014-10-02 | 2019-06-11 | Temple University Of The Commonwealth System Of Higher Education | Synthesis of cell penetrating peptides for drug delivery and stem cell applications |
| CN108064229B (zh) * | 2015-03-12 | 2021-12-28 | 三洋化成工业株式会社 | 蛋白质组合物的制造方法和蛋白质组合物 |
| US9738687B2 (en) * | 2015-04-10 | 2017-08-22 | Feldan Bio Inc. | Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same |
-
2020
- 2020-07-02 JP JP2021578241A patent/JP7581264B2/ja active Active
- 2020-07-02 CA CA3144963A patent/CA3144963A1/en active Pending
- 2020-07-02 EP EP20854383.5A patent/EP3994151A4/en active Pending
- 2020-07-02 CN CN202080055898.6A patent/CN114555625B/zh active Active
- 2020-07-02 KR KR1020227003440A patent/KR20220039725A/ko active Pending
- 2020-07-02 WO PCT/US2020/040720 patent/WO2021034418A2/en not_active Ceased
- 2020-07-02 AU AU2020332268A patent/AU2020332268B2/en not_active Expired - Fee Related
-
2021
- 2021-12-30 IL IL289516A patent/IL289516A/en unknown
- 2021-12-30 US US17/646,496 patent/US11713337B2/en active Active
-
2023
- 2023-06-08 US US18/331,851 patent/US20230340024A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7503590B2 (ja) | 遺伝子構築物 | |
| JP2021503914A5 (https=) | ||
| RU2018142768A (ru) | Варианты капсидов аденоассоциированного вируса и способы их применения | |
| CN108064163B (zh) | 血管生成性疾病的免疫疗法 | |
| JP2021511030A5 (https=) | ||
| EP4563704A1 (en) | Gene delivery vector for delivering human vegf receptor fusion protein and use thereof | |
| US20240050527A1 (en) | METHODS OF TREATING AGE-RELATED MACULAR DISEASES USING AIMP2-DX2 AND OPTIONALLY A TARGET SEQUENCE FOR miR-142 AND COMPOSITIONS THEREOF | |
| US20230340024A1 (en) | Novel peptide, compositions and method for delivery of agents into cells and tissues | |
| JPWO2021034418A5 (https=) | ||
| JP2023531289A (ja) | 眼病態の処置のためのｄｎａ構造 | |
| JPWO2021041373A5 (https=) | ||
| US20160213701A1 (en) | Methods and compositions for treatment of retinal degenerative diseases | |
| US20050106729A1 (en) | Gene transfer methods and compositions | |
| JPWO2023198050A5 (https=) | ||
| RU2023130643A (ru) | Композиции и способы для лечения заболевания глаз, ассоциированного с ангиогенезом | |
| WO2025074268A1 (en) | Methods for treating macular degeneration | |
| Chan | Association for Research in Vision and Ophthalmology (ARVO) 2017 Annual Meeting. Baltimore, Maryland, USA-May 7-11, 2017 | |
| EA048792B1 (ru) | СПОСОБЫ ЛЕЧЕНИЯ ВОЗРАСТНОЙ МАКУЛОДИСТРОФИИ С ПРИМЕНЕНИЕМ AIMP2-DX2 И, НЕОБЯЗАТЕЛЬНО, ПОСЛЕДОВАТЕЛЬНОСТИ-МИШЕНИ ДЛЯ miR-142 И ИХ КОМПОЗИЦИЙ | |
| WO2020120480A1 (en) | Vasodilators for use in the treatment of a retinal ischemic disorder | |
| RU2020121215A (ru) | Варианты капсидов аденоассоциированного вируса и их применение для ингибирования ангиогенеза | |
| NZ765038B2 (en) | Adeno-associated virus variant capsids and use for inhibiting angiogenesis | |
| JP2006516112A5 (https=) |